NEW YORK (GenomeWeb News) – The UK government has awarded £58.7 million ($96.7 million) to a research center at King's College London and Guy's and St. Thomas', a National Health Service trust with two hospitals in London, that will engage in translational research, including biomarker and drug discovery studies.
The Biomedical Research Centre will use the five-year funding to establish the School of Translational and Experimental Medicine and to capitalize upon earlier investments made in new facilities and training programs, according to Guy's and St. Thomas'.
"We will focus on pulling through early discovery of new drugs, molecules and biomarkers into the clinic – and then extending these beyond the hospital and into the wider community through close collaboration with primary care," Guy's and St. Thomas' Chief Executive Ron Kerr said in a statement. "Our scientists and clinicians are at the forefront of developing some of the latest diagnostic techniques and therapeutics so that we can tailor both diagnosis and treatment to individual patients."
The new funding for the Centre was part of a new round of £112 million for research from the National Institute of Health Research that includes £53.3 million to establish mental health research centers.